Eli Lilly Shares Surge Following Record Q4 Earnings and Upbeat 2026 Forecast
Eli Lilly Shares Surge Following Record Q4 Earnings and Upbeat 2026 Forecast INDIANAPOLIS / FRANKFURT, 4 February 2026 – Eli Lilly and Company (LLY) has reported fourth-quarter financial results for 2025 that significantly exceeded Wall Street expectations, propelled by the explosive demand for its incretin therapies, Mounjaro and Zepbound. The pharmaceutical giant also issued a […]
Eli Lilly Shares Surge Following Record Q4 Earnings and Upbeat 2026 Forecast Read More »
